Description: Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. The company offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. It also provides other healthcare products, such as balms, creams, lotions, lozenges, nasal inhalers, over the counter products, petroleum jellies, powders, roll-ons, shampoos, soaps, solutions, sprays, syrups, and vaginal washes. In addition, the company offers therapeutic products consisting of anti-bacterial, anti-biotic, anti-diabetic, anti-diarrheal, anti-emetic, anti-fungal, anti-haemorrhoidal, anti-helmintic, anti-infective, anti-inflammatory, anti-malarial, anti-microbial, anti-migraine, anti-oxidant, anti-protozoal, anti-pyretic, anti-septic, anti-spasmodic, anti-ulcer, and anti-ulcerant; and analgesic, antacid, anxiolytic, appetizer, cough syrup, erectile dysfunction, haematinic, hand sanitizer, health supplement, insecticide, laryngitis, pharyngitis, laxative, lubricant, mosquito repellant, nasal decongestant, nutritional supplement, moisturizer, prickly heat powder, skin lightening lotion, vaginal contraceptive, vaginal hygiene, and vitamin supplements, as well as medicated, complexion, moisturizing, and total protection soaps. It also exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.
Home Page: www.blissgvs.com
102, Hyde Park
Mumbai,
400072
India
Phone:
91 22 4216 0000
Officers
| Name | Title |
|---|---|
| Mr. Shibroor Narsimha Kamath | CEO, MD & Exec. Director |
| Mr. Vipul Babulal Thakkar | Chief Financial Officer |
| Ms. Aditi H. Bhatt | Compliance Officer & Company Sec. |
| Dr. Vibha Gagan Sharma | Exec. & Whole Time Director |
| Ms. Shruti N. Vishal Rao | Exec. & Whole Time Director |
Exchange: BSE
Country: IN
Currency: Indian Rupee (INR)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 24.6003 |
| Price-to-Book MRQ: | 2.1906 |
| Price-to-Sales TTM: | 3.1425 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 0 |